← Pediatrix Medical Group, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $55.7m | $60.2m | $36.7m | $112.8m | $1.1b | $387.4m | $9.8m | $73.3m | $229.9m | $375.2m | |
| Short-term Investments | — | — | — | $0 | — | — | — | — | — | — | |
| Assets, Current | $587.1m | $627.2m | $657.4m | $731.5m | $1.5b | $840.6m | $428.0m | $483.5m | $639.6m | $763.5m | |
| Property, Plant and Equipment, Net | $103.1m | $123.5m | $133.0m | $94.5m | $76.2m | $70.2m | $73.3m | $75.6m | $39.2m | $39.2m | |
| Goodwill | $3.8b | $4.3b | $4.4b | $2.7b | $1.5b | $1.5b | $1.5b | $1.4b | $1.2b | $1.3b | |
| Operating Lease, Right-of-Use Asset | — | — | — | $82.8m | $44.9m | $51.3m | $55.8m | $61.7m | $34.1m | $31.1m | |
| Other Assets, Noncurrent | $56.5m | $91.9m | $103.5m | $90.0m | $107.4m | $131.0m | $123.2m | $82.2m | $76.6m | $58.2m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $495.3m | $504.0m | $542.3m | $498.9m | $241.9m | $301.8m | $296.8m | $272.3m | $260.0m | $229.7m | |
| Assets | $5.3b | $5.9b | $5.9b | $4.1b | $3.3b | $2.7b | $2.3b | $2.2b | $2.2b | $2.2b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $23.3m | $18.9m | $19.7m | $21.6m | $21.1m | $12.7m | $11.6m | |
| Accounts Payable, Current | $28.5m | $34.6m | $31.1m | $39.6m | $59.8m | $36.6m | $31.9m | $34.6m | $46.4m | $37.2m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $67.0m | $41.0m | $41.4m | $44.2m | $47.2m | $31.9m | $25.7m | |
| Long-term Debt, Current Maturities | $20.0m | — | — | — | — | — | — | — | — | — | |
| Long-term Debt, Excluding Current Maturities | $1.7b | — | — | — | — | — | — | — | — | — | |
| Liabilities, Current | $448.9m | $531.4m | $500.2m | $541.8m | $444.3m | $427.4m | $427.0m | $388.9m | $434.1m | $458.9m | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | $61.7m | $41.4m | $33.6m | $34.3m | $34.2m | $57.0m | |
| Other Liabilities, Noncurrent | $45.2m | $57.9m | $32.3m | $22.9m | $45.3m | $42.3m | $39.4m | $30.6m | $32.9m | $30.3m | |
| Long-term Debt | $1.7b | $1.8b | $2.0b | $1.7b | $1.7b | $989.7m | $637.2m | $622.2m | $611.2m | — | |
| Deferred Tax Liabilities, Net | $207.6m | $133.0m | $109.3m | — | — | — | — | — | — | — | |
| Liabilities | $2.6b | $2.8b | $2.8b | $2.6b | $2.6b | $1.8b | $1.5b | $1.4b | $1.4b | $1.4b | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $937k | $937k | $878k | $842k | $856k | $864k | $829k | $840k | $859k | $830k | |
| Retained Earnings (Accumulated Deficit) | $1.8b | $2.0b | $2.1b | $510.2m | ($286.4m) | ($155.4m) | ($89.1m) | $149.5m | ($248.5m) | ($83.2m) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | — | — | — | $3.5m | $1.3m | ($3.7m) | $2.2m | ($1.1m) | $610k | |
| Additional Paid in Capital, Common Stock | $974.3m | $1.0b | $992.6m | $987.9m | $1.0b | $1.0b | $983.6m | $999.9m | $1.0b | $947.6m | |
| Stockholders' Equity Attributable to Parent | $2.8b | $3.1b | $3.1b | $1.5b | $747.5m | $896.5m | $891.6m | $849.1m | $764.9m | $865.9m | |
| Stockholders' Equity Attributable to Noncontrolling Interest | — | — | — | — | $232k | $205k | $0 | — | — | — | |
| Liabilities and Equity | $5.3b | $5.9b | $5.9b | $4.1b | $3.3b | $2.7b | $2.3b | $2.2b | $2.2b | $2.2b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.